Guided Therapeutics (GTHP) Other Gross PP&E Adjustments (2019 - 2025)
Guided Therapeutics (GTHP) has disclosed Other Gross PP&E Adjustments for 9 consecutive years, with -$686000.0 as the latest value for Q4 2025.
- Quarterly Other Gross PP&E Adjustments fell 386.52% to -$686000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$686000.0 through Dec 2025, down 386.52% year-over-year, with the annual reading at -$686000.0 for FY2025, 386.52% down from the prior year.
- Other Gross PP&E Adjustments hit -$686000.0 in Q4 2025 for Guided Therapeutics, down from -$69000.0 in the prior quarter.
- In the past five years, Other Gross PP&E Adjustments ranged from a high of -$69000.0 in Q3 2025 to a low of -$686000.0 in Q4 2025.
- Historically, Other Gross PP&E Adjustments has averaged -$300500.0 across 5 years, with a median of -$303000.0 in 2022.
- Biggest five-year swings in Other Gross PP&E Adjustments: crashed 536.07% in 2021 and later skyrocketed 69.61% in 2024.
- Year by year, Other Gross PP&E Adjustments stood at -$372000.0 in 2021, then dropped by 29.3% to -$481000.0 in 2022, then grew by 3.53% to -$464000.0 in 2023, then surged by 69.61% to -$141000.0 in 2024, then crashed by 386.52% to -$686000.0 in 2025.
- Business Quant data shows Other Gross PP&E Adjustments for GTHP at -$686000.0 in Q4 2025, -$69000.0 in Q3 2025, and -$94000.0 in Q2 2025.